---
title: "Tianxing Medical Surges Over 192% on Hong Kong Debut"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285141013.md"
description: "Tianxing Medicalhad a remarkable debut on the Hong Kong Stock Exchange, opening at HKD 288, a rise of over 192% from its IPO price of HKD 98.5. This strong performance indicates significant investor interest and confidence in the company's market potential, as reported by Jin10."
datetime: "2026-05-05T01:24:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285141013.md)
  - [en](https://longbridge.com/en/news/285141013.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285141013.md)
---

# Tianxing Medical Surges Over 192% on Hong Kong Debut

Tianxing Medical (01609.HK) made a strong debut on the Hong Kong Stock Exchange, opening at HKD 288, which marks an increase of over 192% from its initial public offering price of HKD 98.5. According to Jin10, the company's impressive performance on its first trading day reflects strong investor interest and confidence in its market potential.

### Related Stocks

- [01609.HK](https://longbridge.com/en/quote/01609.HK.md)

## Related News & Research

- [Star Sports Medicine plans repurchase of up to 2.9 million H shares under buyback mandate](https://longbridge.com/en/news/296203978.md)
- [China Traditional Chinese Medicine Holdings schedules board meeting to review interim results](https://longbridge.com/en/news/296200801.md)
- [11:06 ETEndurance Named to Inc. 5000 for 11th Time, Continuing National Growth](https://longbridge.com/en/news/296124358.md)
- [Golden Power Group completes placement of 6,492,000 shares at HK$ 0.65 each](https://longbridge.com/en/news/296091998.md)
- [CStone says China NMPA clears IND for CS5007 EGFR/HER3 bispecific ADC](https://longbridge.com/en/news/296540686.md)